EBALZOTAN
UNII WV4B56N49H

Substance Identification & Data

This profile provides standardized clinical and technical data for Ebalzotan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WV4B56N49H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 149494-37-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WV4B56N49H

CAS Registry Number

149494-37-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EBALZOTAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H30N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UEAKCKJAKUFIQP-OAHLLOKOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C72746

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9797080

Unique identification number in the NCBI database of chemical substances.

INN ID

7065

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1[C@@H](Cc2c(cccc2O1)C(=O)NC(C)C)N(CCC)C(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ebalzotan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.